4.4 Letter

Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Karen Claesen et al.

Summary: This paper provides an overview of Procarboxypeptidase U and related research, highlighting the novel concept of using CPU inhibitors as profibrinolytic agents, as well as the potential significance and clinical applications of CPU in thromboembolic diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Obstetrics & Gynecology

Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome

Anne C. M. Godtfredsen et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)

Article Biotechnology & Applied Microbiology

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction

Tajinder Kumar Parpugga et al.

DISEASE MARKERS (2015)